Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
Kwang Su Kim, Keisuke Ejima, Shoya Iwanami, et al.
PLoS Biology (2021) Vol. 19, Iss. 3, pp. e3001128-e3001128
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks
Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Mechanistic Modeling of SARS‐CoV‐2 and Other Infectious Diseases and the Effects of Therapeutics
Alan S. Perelson, Ruian Ke
Clinical Pharmacology & Therapeutics (2021) Vol. 109, Iss. 4, pp. 829-840
Open Access | Times Cited: 94
Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted by COVID-19 Patients while Breathing, Talking, and Singing
Kristen K. Coleman, Douglas Jie Wen Tay, Kai Sen Tan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 58
Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance
Sonali Chaturvedi, Gustavo Vasen, Michael Pablo, et al.
Cell (2021) Vol. 184, Iss. 25, pp. 6022-6036.e18
Open Access | Times Cited: 57
Modeling how antibody responses may determine the efficacy of COVID-19 vaccines
Pranesh Padmanabhan, Rajat Desikan, Narendra M. Dixit
Nature Computational Science (2022) Vol. 2, Iss. 2, pp. 123-131
Open Access | Times Cited: 52
Public Health Impact of Paxlovid as Treatment for COVID-19, United States
Yuan Bai, Zhanwei Du, Lin Wang, et al.
Emerging infectious diseases (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 11
Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses
Katherine Owens, Shadisadat Esmaeili, Joshua T. Schiffer
JCI Insight (2024) Vol. 9, Iss. 9
Open Access | Times Cited: 11
How robust are estimates of key parameters in standard viral dynamic models?
Carolin Zitzmann, Ruian Ke, Ruy M. Ribeiro, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 4, pp. e1011437-e1011437
Open Access | Times Cited: 7
A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy
Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study
Shoya Iwanami, Keisuke Ejima, Kwang Su Kim, et al.
PLoS Medicine (2021) Vol. 18, Iss. 7, pp. e1003660-e1003660
Open Access | Times Cited: 52
Immune response to SARS-CoV-2 in severe disease and long COVID-19
Tomonari Sumi, Kouji Harada
iScience (2022) Vol. 25, Iss. 8, pp. 104723-104723
Open Access | Times Cited: 31
Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2
Wakana Saso, Masako Yamasaki, Shin‐ichi Nakakita, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010590-e1010590
Open Access | Times Cited: 29
Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms
Budhaditya Chatterjee, Harshbir Singh Sandhu, Narendra M. Dixit
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010630-e1010630
Open Access | Times Cited: 29
Towards systems immunology of critical illness at scale: from single cell ‘omics to digital twins
Yoram Vodovotz
Trends in Immunology (2023) Vol. 44, Iss. 5, pp. 345-355
Open Access | Times Cited: 16
Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments
Daisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 5, pp. 591-603
Open Access | Times Cited: 15
Defining the Critical Requisites for Accurate Simulation of SARS‐CoV‐2 Viral Dynamics: Patient Characteristics and Data Collection Protocol
H.C. Chua, Ananya Singh, Yuqian Wang, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M. Ribeiro, Gregory E. Edelstein, et al.
Journal of Virology (2025)
Open Access
Age- and vaccination status-dependent isolation guidelines based on simulation of SARS-CoV-2 Delta cases in Singapore
Keisuke Ejima, Marco Ajelli, Ananya Singh, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Revisiting the guidelines for ending isolation for COVID-19 patients
Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 36
Designing isolation guidelines for COVID-19 patients with rapid antigen tests
Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)
T. Kinoshita, Masahiro Shinoda, Yasuhiro Nishizaki, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 25
Dynamical Behavior of a Fractional Order Model for Within-Host SARS-CoV-2
Kaushik Dehingia, A. Mohsen, Sana Abdulkream Alharbi, et al.
Mathematics (2022) Vol. 10, Iss. 13, pp. 2344-2344
Open Access | Times Cited: 24
Identifiability of parameters in mathematical models of SARS-CoV-2 infections in humans
Stanca M. Ciupe, Necibe Tuncer
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
A simple model of COVID-19 explains disease severity and the effect of treatments
Steven Sanche, Tyler Cassidy, P.-H. Chu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
A quantitative systems pharmacology model of the pathophysiology and treatment of COVID-19 predicts optimal timing of pharmacological interventions
Rohit Rao, Cynthia J. Musante, Richard Allen
npj Systems Biology and Applications (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top